X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.fiercebiotech.com/biotech/akt-over-roche-dumps-phase-3-prostate-cancer-prospect
https://www.fiercebiotech.com/biotech/roche-scraps-5-trials-while-ceo-admits-alzheimers-tigit-ambitions-remain-risky-bets
https://www.fiercebiotech.com/biotech/roche-chucks-out-phase-3-ipatasertib-combo-tests-midstage-il-33-asthma-btki-arthritis
https://www.fiercebiotech.com/biotech/esmo-roche-s-akt-inhibitor-scores-slight-win-over-j-j-s-zytiga
https://www.clinicaltrialsarena.com/news/su2c-clinical-trials-teams-launch/
http://www.pharmatimes.com/news/roches_ipatasertib_combo_shows_early_promise_in_triple-negative_breast_cancer_1283208
http://www.pmlive.com/pharma_news/tecentriq_combo_shows_promise_in_triple_negative_breast_cancer_1283071
Market Place
Share 
